Personalized Medicine: Promises and Perils

Personalized Medicine: Promises and Perils

The University of San Diego School of Law and the Center for Health Law Policy and Bioethics is pleased to present "Personalized Medicine: Promises and Perils." A panel of three experts will examine advances in genomic and digital health and evaluate their distinctive potential to bring greater health and longevity alongside their special risks to individual privacy and discrimination. 

Program Schedule
5 - 6 pm Check-in/Networking Reception
6 - 7:30 pm Presentation 

 

 

Panelists  

Topol

Eric Topol, Founder and Director of Scripps Translational Science Institute (STSI), Professor, Molecular Medicine, and Executive Vice-President of Scripps Research Institute (TSRI)

 

Eric Topol is the Founder and Director of the Scripps Translational Science Institute (STSI), Professor, Molecular Medicine, and Executive Vice-President of The Scripps Research Institute (TSRI). As a researcher, he has published over 1100 peer-reviewed articles, with more than 185,000 citations, elected to the National Academy of Medicine, and is one of the top 10 most cited researchers in medicine (Thomson Reuters ISI, “Doctor of the Decade”). His principal scientific focus has been on the genomic and digital tools to individualize medicine—and the power that brings to individuals to drive the future of medicine.

In 2016, Topol was awarded a $207M grant from the NIH to lead a significant part of the Precision Medicine Initiative, a prospective research program that aims to enroll 1 million participants in the US. Prior to coming to lead Scripps STSI in 2007, for which he is the principal investigator of a flagship $33M NIH grant, he led the Cleveland Clinic to become the #1 center for heart care and was the founder of a new medical school there. He has been voted as the #1 most Influential physician leader in the United States in a national poll conducted by Modern Healthcare. Besides editing several textbooks, he has published 2 bestseller books on the future of medicine: The Creative Destruction of Medicine and The Patient Will See You Now.

Epstein Robert Epstein, Senior Research Psychologist at American Institute for Behavioral Research and Technology (AIBRT)
Mohasseb

 

Sid Mohasseb, Published Author and Adjunct Professor at the University of Southern California

 

 

Stephen Ferruolo, Dean School of Law

Dov Fox, Moderator

MCLE

University of San Diego School of Law is a State Board of California-approved MCLE provider and is currently evaluating credits for this activity. Please check back for more information. 

About the Center for Health Law Policy and Bioethics

San Diego is a world leader in biotechnology and medical technology and at the forefront of many innovative scientific breakthroughs. As a community, we have come to realize that scientific and medical advancement, however promising, is often impeded and many innovations fail to fully realize their potential for improving human health because they raise challenging ethical, legal or policy issues. The Center for Health Law Policy & Bioethics has been established to provide an interdisciplinary and inter-institutional forum to address these issues and to support research, education, and policy reform. 

Personalized Medicine

Post Contact

Stacee Groff
sgroff@sandiego.edu
(619) 260-4208

Phone

Contact Us

Phone: (619) 260-4527
lawdean@sandiego.edu

View Directory

83° 61°

Visit Campus

Warren Hall, Room 201
5998 Alcalá Park
San Diego, CA 92110